Table 5. Consumption of foods and drinks that promote weight gain and breast cancer risk among EA women by menopausal status.
| (frequency of intake/week) | All women | Premenopausal (n=774) | Postmenopausal (n=682) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ca (n) | Co (n) | OR1 | 95% CI | OR2 | 95% CI | Ca (n) | Co (n) | OR1 | 95% CI | OR2 | 95% CI | Ca (n) | Co (n) | OR1 | 95% CI | OR2 | 95% CI | |
| Energy dense foods | ||||||||||||||||||
| Q1 (≤3) | 181 | 198 | Ref | Ref | 93 | 90 | Ref | Ref | 88 | 108 | Ref | Ref | ||||||
| Q2 (3.1-6) | 175 | 151 | 1.28 | 0.93-1.75 | 1.32 | 0.96-1.81 | 76 | 86 | 0.81 | 0.51-1.29 | 0.80 | 0.50-1.27 | 99 | 65 | 1.73 | 1.09-2.74 | 1.91 | 1.19-3.06 |
| Q3 (6.1-11) | 202 | 184 | 1.27 | 0.94-1.73 | 1.36 | 0.99-1.86 | 112 | 105 | 0.97 | 0.63-1.50 | 0.93 | 0.59-1.45 | 90 | 79 | 1.64 | 1.03-2.60 | 2.05 | 1.26-3.32 |
| Q4 (>11) | 197 | 168 | 1.37 | 1.01-1.87 | 1.57 | 1.10-2.24 | 108 | 104 | 1.14 | 0.74-1.75 | 1.04 | 0.64-1.70 | 89 | 64 | 1.82 | 1.12-2.95 | 2.95 | 1.66-5.22 |
| P for linear trend | 0.08 | 0.02 | 0.31 | 0.59 | 0.03 | 0.001 | ||||||||||||
| Fast foods | ||||||||||||||||||
| Q1 (≤1) | 164 | 187 | Ref | Ref | 69 | 73 | Ref | Ref | 95 | 114 | Ref | Ref | ||||||
| Q2 (1.1-2) | 196 | 180 | 1.49 | 1.09-2.03 | 1.51 | 1.11-2.07 | 87 | 98 | 1.16 | 0.72-1.88 | 1.15 | 0.71-1.86 | 109 | 82 | 1.97 | 1.26-3.07 | 2.05 | 1.30-3.21 |
| Q3 (2.1-3) | 156 | 132 | 1.67 | 1.19-2.35 | 1.74 | 1.23-2.45 | 86 | 76 | 1.53 | 0.92-2.52 | 1.49 | 0.89-2.48 | 70 | 56 | 1.83 | 1.11-3.03 | 1.99 | 1.19-3.30 |
| Q4 (>3) | 239 | 202 | 1.60 | 1.16-2.19 | 1.75 | 1.24-2.46 | 147 | 138 | 1.46 | 0.92-2.31 | 1.39 | 0.85-2.27 | 92 | 64 | 1.81 | 1.12-2.95 | 2.35 | 1.38-4.00 |
| P for linear trend | 0.02 | 0.005 | 0.11 | 0.21 | 0.04 | 0.004 | ||||||||||||
| Sugary drinks | ||||||||||||||||||
| None | 524 | 512 | Ref | Ref | 248 | 263 | Ref | Ref | 276 | 249 | Ref | Ref | ||||||
| Low (≤1) | 125 | 120 | 1.08 | 0.80-1.45 | 1.09 | 0.80-1.46 | 86 | 76 | 1.13 | 0.77-1.65 | 1.10 | 0.75-1.62 | 39 | 44 | 0.86 | 0.52-1.44 | 0.88 | 0.53-1.47 |
| High (>1) | 106 | 69 | 1.28 | 0.90-1.84 | 1.31 | 0.91-1.89 | 55 | 46 | 1.01 | 0.62-1.64 | 0.95 | 0.58-1.56 | 51 | 23 | 1.92 | 1.07-3.44 | 2.05 | 1.13-3.70 |
| P for linear trend | 0.18 | 0.15 | 0.97 | 0.80 | 0.03 | 0.02 | ||||||||||||
Ca – case; Co- control
OR1: Adjusted for age, ethnicity, country of origin, education, age at menarche, menopausal status, parity, age at first birth, breastfeeding status, family history of breast cancer, HRT use, OC use, history of benign breast disease, study site, BMI, total MET hours per week; OR2: Further adjusted for total energy intake